Author response to "lack of benefit from low dose computed tomography in screening for lung cancer"

0Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

We explain to Dr. Benjamin (corresponding author) about why low-dose computed tomography reduce lung cancer mortality without significantly reducing all-cause mortality. We also conduct an up-to-date meta-analysis to evaluate low-dose computed tomography clinical effectiveness compared with usual care of lung cancer screening.

References Powered by Scopus

Reduced lung-cancer mortality with volume CT screening in a randomized trial

2290Citations
N/AReaders
Get full text

Lung cancer mortality reduction by LDCT screening—Results from the randomized German LUSI trial

358Citations
N/AReaders
Get full text

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

0
327Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Huang, K. L., Wang, S. Y., Lu, W. C., Chang, Y. H., Su, J., & Lu, Y. T. (2020). Author response to “lack of benefit from low dose computed tomography in screening for lung cancer.” BMC Pulmonary Medicine, 20(1). https://doi.org/10.1186/s12890-020-01247-y

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

90%

Nursing and Health Professions 1

10%

Save time finding and organizing research with Mendeley

Sign up for free